0000899243-19-029402.txt : 20191217 0000899243-19-029402.hdr.sgml : 20191217 20191217160541 ACCESSION NUMBER: 0000899243-19-029402 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191213 FILED AS OF DATE: 20191217 DATE AS OF CHANGE: 20191217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alleva Lawrence M CENTRAL INDEX KEY: 0001553053 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39114 FILM NUMBER: 191289747 MAIL ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 3300 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Galera Therapeutics, Inc. CENTRAL INDEX KEY: 0001563577 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461454898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 WEST LIBERTY BLVD #100 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-725-1500 MAIL ADDRESS: STREET 1: 2 WEST LIBERTY BLVD #100 CITY: MALVERN STATE: PA ZIP: 19355 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-13 0 0001563577 Galera Therapeutics, Inc. GRTX 0001553053 Alleva Lawrence M C/O GALERA THERAPEUTICS, INC., 2 W LIBERTY BLVD #100 MALVERN PA 19355 1 0 0 0 Common Stock 2019-12-13 4 P 0 4000 9.7847 A 4000 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.25 to $9.8773, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ J. Mel Sorensen, Attorney-in-Fact for Lawrence Alleva 2019-12-17